Predictors of outcome for renal artery stenting performed for salvage of renal function

J. Gregory Modrall, Carlos H. Timaran, Eric B. Rosero, Jayer Chung, Frank A. Arko, R. James Valentine, G. Patrick Clagett, Clayton Trimmer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To identify preoperative clinical features that predict a durable improvement in renal function with renal artery stenting (RAS). Methods: Sixty-one patients with renal insufficiency (serum creatinine <1.5 mg/dL) underwent RAS for renal salvage. Patients were categorized as "responders" if estimated glomerular filtration rate (eGFR) at last follow-up was improved 20% or more over baseline. Patients with stable or worse renal function after RAS were labeled "non-responders." For the purpose of calculating changes in eGFR, patients on dialysis were represented by an eGFR of 10 ml/min/1.73 m 2. Renal volume was estimated as kidney length × width × depth/2. Results: The median age of the cohort was 66 years (interquartile range [IQR], 60-73 years). Median preoperative serum creatinine was 1.8 mg/dL (IQR, 1.6-2.3), and median estimated glomerular filtration rate (eGFR) was 34 mL/min/1.73 m 2 (IQR, 24-45). With stenting, 17 of 61 patients (27.9%) derived a durable improvement in renal function at a median follow-up of 24 months (IQR, 16-33 months). The largest proportion of stented patients (44.3%) had no improvement in renal function after stenting, while a subset (27.9%) experienced a decline in renal function. Responders enjoyed a 47% improvement in renal function from baseline, while non-responders had a 13% decrement in renal function (P < .0001). Responders had a higher baseline serum creatinine, lower eGFR, and a steeper decline in renal function prior to RAS, compared with non-responders. Kidney length, width, depth, and volume were not significantly different between responders and non-responders. Logistic regression analysis identified the rate of decline of renal function prior to stenting as the only independent preoperative predictor of improved renal function after RAS (odds ratio, 3.4; 95% confidence interval, 1.6 to 7.5; P = .0019). The rate of decline in eGFR per week was more than 20-fold greater for responders than non-responders (2.1% vs 0% decline in eGFR per week; P < .0001). No predictors of renal function deterioration after stenting were identified. Conclusions: The current study found that a steep decline in preoperative renal function portends a higher likelihood of renal salvage from RAS among patients with renal insufficiency. Incorporating this finding into patient selection may improve outcomes for RAS.

Original languageEnglish (US)
JournalJournal of Vascular Surgery
Volume54
Issue number5
DOIs
StatePublished - Nov 2011

Fingerprint

Renal Artery
Kidney
Glomerular Filtration Rate
Creatinine
Renal Insufficiency
Serum
Patient Selection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Predictors of outcome for renal artery stenting performed for salvage of renal function. / Modrall, J. Gregory; Timaran, Carlos H.; Rosero, Eric B.; Chung, Jayer; Arko, Frank A.; Valentine, R. James; Clagett, G. Patrick; Trimmer, Clayton.

In: Journal of Vascular Surgery, Vol. 54, No. 5, 11.2011.

Research output: Contribution to journalArticle

@article{d068a8eefeef436aaa76a83aa10b1554,
title = "Predictors of outcome for renal artery stenting performed for salvage of renal function",
abstract = "Objective: To identify preoperative clinical features that predict a durable improvement in renal function with renal artery stenting (RAS). Methods: Sixty-one patients with renal insufficiency (serum creatinine <1.5 mg/dL) underwent RAS for renal salvage. Patients were categorized as {"}responders{"} if estimated glomerular filtration rate (eGFR) at last follow-up was improved 20{\%} or more over baseline. Patients with stable or worse renal function after RAS were labeled {"}non-responders.{"} For the purpose of calculating changes in eGFR, patients on dialysis were represented by an eGFR of 10 ml/min/1.73 m 2. Renal volume was estimated as kidney length × width × depth/2. Results: The median age of the cohort was 66 years (interquartile range [IQR], 60-73 years). Median preoperative serum creatinine was 1.8 mg/dL (IQR, 1.6-2.3), and median estimated glomerular filtration rate (eGFR) was 34 mL/min/1.73 m 2 (IQR, 24-45). With stenting, 17 of 61 patients (27.9{\%}) derived a durable improvement in renal function at a median follow-up of 24 months (IQR, 16-33 months). The largest proportion of stented patients (44.3{\%}) had no improvement in renal function after stenting, while a subset (27.9{\%}) experienced a decline in renal function. Responders enjoyed a 47{\%} improvement in renal function from baseline, while non-responders had a 13{\%} decrement in renal function (P < .0001). Responders had a higher baseline serum creatinine, lower eGFR, and a steeper decline in renal function prior to RAS, compared with non-responders. Kidney length, width, depth, and volume were not significantly different between responders and non-responders. Logistic regression analysis identified the rate of decline of renal function prior to stenting as the only independent preoperative predictor of improved renal function after RAS (odds ratio, 3.4; 95{\%} confidence interval, 1.6 to 7.5; P = .0019). The rate of decline in eGFR per week was more than 20-fold greater for responders than non-responders (2.1{\%} vs 0{\%} decline in eGFR per week; P < .0001). No predictors of renal function deterioration after stenting were identified. Conclusions: The current study found that a steep decline in preoperative renal function portends a higher likelihood of renal salvage from RAS among patients with renal insufficiency. Incorporating this finding into patient selection may improve outcomes for RAS.",
author = "Modrall, {J. Gregory} and Timaran, {Carlos H.} and Rosero, {Eric B.} and Jayer Chung and Arko, {Frank A.} and Valentine, {R. James} and Clagett, {G. Patrick} and Clayton Trimmer",
year = "2011",
month = "11",
doi = "10.1016/j.jvs.2011.04.042",
language = "English (US)",
volume = "54",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Predictors of outcome for renal artery stenting performed for salvage of renal function

AU - Modrall, J. Gregory

AU - Timaran, Carlos H.

AU - Rosero, Eric B.

AU - Chung, Jayer

AU - Arko, Frank A.

AU - Valentine, R. James

AU - Clagett, G. Patrick

AU - Trimmer, Clayton

PY - 2011/11

Y1 - 2011/11

N2 - Objective: To identify preoperative clinical features that predict a durable improvement in renal function with renal artery stenting (RAS). Methods: Sixty-one patients with renal insufficiency (serum creatinine <1.5 mg/dL) underwent RAS for renal salvage. Patients were categorized as "responders" if estimated glomerular filtration rate (eGFR) at last follow-up was improved 20% or more over baseline. Patients with stable or worse renal function after RAS were labeled "non-responders." For the purpose of calculating changes in eGFR, patients on dialysis were represented by an eGFR of 10 ml/min/1.73 m 2. Renal volume was estimated as kidney length × width × depth/2. Results: The median age of the cohort was 66 years (interquartile range [IQR], 60-73 years). Median preoperative serum creatinine was 1.8 mg/dL (IQR, 1.6-2.3), and median estimated glomerular filtration rate (eGFR) was 34 mL/min/1.73 m 2 (IQR, 24-45). With stenting, 17 of 61 patients (27.9%) derived a durable improvement in renal function at a median follow-up of 24 months (IQR, 16-33 months). The largest proportion of stented patients (44.3%) had no improvement in renal function after stenting, while a subset (27.9%) experienced a decline in renal function. Responders enjoyed a 47% improvement in renal function from baseline, while non-responders had a 13% decrement in renal function (P < .0001). Responders had a higher baseline serum creatinine, lower eGFR, and a steeper decline in renal function prior to RAS, compared with non-responders. Kidney length, width, depth, and volume were not significantly different between responders and non-responders. Logistic regression analysis identified the rate of decline of renal function prior to stenting as the only independent preoperative predictor of improved renal function after RAS (odds ratio, 3.4; 95% confidence interval, 1.6 to 7.5; P = .0019). The rate of decline in eGFR per week was more than 20-fold greater for responders than non-responders (2.1% vs 0% decline in eGFR per week; P < .0001). No predictors of renal function deterioration after stenting were identified. Conclusions: The current study found that a steep decline in preoperative renal function portends a higher likelihood of renal salvage from RAS among patients with renal insufficiency. Incorporating this finding into patient selection may improve outcomes for RAS.

AB - Objective: To identify preoperative clinical features that predict a durable improvement in renal function with renal artery stenting (RAS). Methods: Sixty-one patients with renal insufficiency (serum creatinine <1.5 mg/dL) underwent RAS for renal salvage. Patients were categorized as "responders" if estimated glomerular filtration rate (eGFR) at last follow-up was improved 20% or more over baseline. Patients with stable or worse renal function after RAS were labeled "non-responders." For the purpose of calculating changes in eGFR, patients on dialysis were represented by an eGFR of 10 ml/min/1.73 m 2. Renal volume was estimated as kidney length × width × depth/2. Results: The median age of the cohort was 66 years (interquartile range [IQR], 60-73 years). Median preoperative serum creatinine was 1.8 mg/dL (IQR, 1.6-2.3), and median estimated glomerular filtration rate (eGFR) was 34 mL/min/1.73 m 2 (IQR, 24-45). With stenting, 17 of 61 patients (27.9%) derived a durable improvement in renal function at a median follow-up of 24 months (IQR, 16-33 months). The largest proportion of stented patients (44.3%) had no improvement in renal function after stenting, while a subset (27.9%) experienced a decline in renal function. Responders enjoyed a 47% improvement in renal function from baseline, while non-responders had a 13% decrement in renal function (P < .0001). Responders had a higher baseline serum creatinine, lower eGFR, and a steeper decline in renal function prior to RAS, compared with non-responders. Kidney length, width, depth, and volume were not significantly different between responders and non-responders. Logistic regression analysis identified the rate of decline of renal function prior to stenting as the only independent preoperative predictor of improved renal function after RAS (odds ratio, 3.4; 95% confidence interval, 1.6 to 7.5; P = .0019). The rate of decline in eGFR per week was more than 20-fold greater for responders than non-responders (2.1% vs 0% decline in eGFR per week; P < .0001). No predictors of renal function deterioration after stenting were identified. Conclusions: The current study found that a steep decline in preoperative renal function portends a higher likelihood of renal salvage from RAS among patients with renal insufficiency. Incorporating this finding into patient selection may improve outcomes for RAS.

UR - http://www.scopus.com/inward/record.url?scp=80054853370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054853370&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2011.04.042

DO - 10.1016/j.jvs.2011.04.042

M3 - Article

C2 - 21803522

AN - SCOPUS:80054853370

VL - 54

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -